Literature DB >> 12975026

Insulin pump therapy for type 2 diabetes.

Susan E Kirk1.   

Abstract

Insulin pump therapy, or continuous subcutaneous insulin infusion, has become an increasingly popular mode of therapy for patients with type 1 diabetes mellitus. Although the benefits of insulin pump therapy, such as less glycemic variability and a more flexible lifestyle, should be similar for patients with type 1 and type 2 diabetes mellitus, data on the use of insulin pump therapy in patients with type 2 diabetes are limited. This article reviews the basic principles of insulin pump therapy, the advantages and disadvantages encountered with its use, and the clinical situations where it may be considered for patients with type 2 diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 12975026     DOI: 10.1007/s11892-003-0080-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  18 in total

1.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

2.  Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

Authors:  C D Saudek; W C Duckworth; A Giobbie-Hurder; W G Henderson; R R Henry; D E Kelley; S V Edelman; F J Zieve; R A Adler; J W Anderson; R J Anderson; B P Hamilton; T W Donner; M S Kirkman; N A Morgan
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

3.  Insulin pump therapy: a meta-analysis.

Authors:  Jill Weissberg-Benchell; Jeanne Antisdel-Lomaglio; Roopa Seshadri
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

4.  Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients.

Authors:  B Lormeau; M H Aurousseau; P Valensi; J Paries; J R Attali
Journal:  Metabolism       Date:  1997-09       Impact factor: 8.694

5.  Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Authors:  H Ilkova; B Glaser; A Tunçkale; N Bagriaçik; E Cerasi
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

6.  Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.

Authors:  A A Rizvi; R Petry; M B Arnold; M Chakraborty
Journal:  Endocr Pract       Date:  2001 Sep-Oct       Impact factor: 3.443

7.  Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

Authors:  Scott A Segel; Deanna S Paramore; Philip E Cryer
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

8.  Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus.

Authors:  B Rosenn; M Miodovnik; C A Combs; J Khoury; T A Siddiqi
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

Review 9.  Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM--the clinical characteristics and pathogenesis of the syndrome.

Authors:  T Kobayashi
Journal:  Diabetes Res Clin Pract       Date:  1994-10       Impact factor: 5.602

10.  Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.

Authors:  J S Thompson; W C Duckworth; C D Saudek; A Giobbie-Hurder
Journal:  Am J Surg       Date:  1998-12       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.